Overview

Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy

Status:
Active, not recruiting

Trial end date:
2025-02-01

Target enrollment:

Participant gender:

Summary

This is a prospective multicenter randomized open-label study aiming to assess whether endocardial or endocardial-epicardial ablation is superior to the standard approach (i.e., Antiarrhythmic drugs) in achievement of long-term ventricular tachycardia (VT) treatment success.

Phase:

Early Phase 1

Details

Lead Sponsor:

Montefiore Medical Center

Treatments:

Anti-Arrhythmia Agents